This is a composition of matter patent on stem cells of the hematopoietic lineage that differentiate specifically into myeloid cells under the appropriate culture and/or in vivo conditions. These stem cells may be used as a "boost" for patients in which the myeloid compartment is not repopulating after bone marrow transplant, or chemotherapy, or radiation therapy.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.